Newsfeeds Archive - Page 7 of 7 - Spark Newswire

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

1 minute read

Legal
News

Today Announced The U.S. District Court Of Delaware Issued An Oral Order In The Matter Of Salix Pharmaceuticals, Ltd. Et Al V. Norwich Pharmaceuticals

By Benzinga Newsdesk

July 28, 3:48 PM

Bausch Health Companies Inc. (TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced the U.S. District Court of Delaware issued an Oral Order in the matter of Salix

Read More

3 minute read

Nasdaq Rises 100 Points; US Economy Shrinks Again In Q2

July 28, 2:34 PM

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday.

Read More

2 minute read

Why Bausch Health’s Market Cap Was Chopped In Half Thursday: ‘A Near Worst-Case Scenario’

July 28, 2:23 PM

Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug.

Read More

5 minute read

Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday’s Mid-Day Session

July 28, 12:41 PM

Gainers

Read More

3 minute read

U.S. Stocks Turn Higher, Dow Surges More Than 200 Points

July 28, 12:06 PM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday.

Read More

1 minute read

Traders Circulate July 14 CreditSights Report ‘Bausch Health faces a critically important patent ruling for Xifaxan in early August.;’ Traders Circulate Speculation Of Legal Issue With Patent

By Benzinga Newsdesk

July 28, 10:01 AM

https://twitter.com/creditsights/status/1547599155970732033

Read More

1 minute read

‘Well-Established’ Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst

By Vandana Singh

July 26, 3:45 PM

RBC Capital markets initiated coverage on Bausch + Lomb Corp (NYSE:BLCO) with an Outperform rating and a $22 price target. The analysts see…

Read More

1 minute read

Analyst Ratings

Expert Ratings for Bausch Health Companies

By Benzinga Insights

July 26, 1:24 PM

Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter: